CODXCo-Diagnostics, Inc.
1.210USD+10.00%Mkt Cap: 7.57M $P/E:

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in …

Key Statistics

Company
Market Cap7.57M $
Enterprise Value5.34M $
Revenue (TTM)721.39K $
Gross Profit400.11K $
Net Income (TTM)-46.90M $
Revenue/Share0.2970 USD
Last Price1.210 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees115
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS1897631057
Valuation
P/E (Trailing)
P/E (Forward)-1.39
PEG
EV/EBITDA-0.18
EV/Revenue7.40
P/S9.97
P/B0.44
EPS (TTM)-27.69
EPS (Forward)-0.83
52W Range
0.95501% of range46.50
52W High46.50 USD
52W Low0.9550 USD
Profitability
Gross Margin64.28%
Oper. Margin-3732.47%
EBITDA Margin0.00%
Profit Margin-7533.62%
ROE-227.33%
ROA-189.54%
Growth
Revenue Growth2.00%
Earnings Growth
Cash Flow & Leverage
Operating CF-29.14M $
CapEx (TTM)700.05K $
FCF Margin-2424.86%
FCF Yield-231.22%
Net Debt-1.85M $
Net Debt/EBITDA0.06
Balance Sheet
Debt/Equity0.06
Current Ratio1.81
Quick Ratio1.29
Book Value/Sh2.606 USD
Cash/Share0.5840 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:30
Split DateJan 2, 2026
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.000 USD
Upside (mean)+230.6%
Target Range4.000 USD4.000 USD
# Analysts1
Ownership
Shares Out.6.25M
Float6.11M
Insiders2.01%
Institutions10.53%
Short Interest
Short Ratio0.6d
Short % Float9.78%
Short % Out.9.46%
Shares Short348.66K
Short (prev mo.)125.61K
Technical
SMA 502.426 (-50.1%)
SMA 2004.201 (-71.2%)
Beta2.88
S&P 52W Chg18.16%
Avg Vol (30d)378.46K
Avg Vol (10d)481.88K
Technical Indicators
RSI (14)25.8
MACD-0.3666
MACD Signal-0.3997
MACD Hist.+0.0330
BB Upper2.209 USD
BB Middle1.589 USD
BB Lower0.9700 USD
BB Width77.95%
ATR (14)0.2861 USD
Vol Ratio (20d)4.15x